An Oxidative Stress Nanoamplifier to Enhance the Efficacy of Cisplatin in Head and Neck Cancer
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202421481 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Zhenzhen Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, P.R. China. Hauptthemen laut MEDLINE: Oxidative Stress, Cisplatin, Antineoplastic Agents, Head and Neck Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Key Research and Development Program of China, New Cornerstone Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Cisplatin (CP) is a first‐line platinum‐based drug used for the treatment of head and neck cancer. However, tumor cells can diminish the therapeutic effects of CP through the detoxification system mediated by glutathione (GSH) and the nucleotide excision repair (NER) pathway. Herein, we present a light‐activable and pH‐responsive oxidative stress nanoamplifier (FPLC@IR OSNA), comprising an amphiphilic compound (FPLC) with Fmoc‐lysine acting as a connector between a nitroimidazole derivative and a pH‐responsive cinnamaldehyde (CA) derivative, loaded with photosensitizer IR780. The acidic microenvironment of the lysosome can trigger the release of CA to produce H 2 O 2 , which breaks down into oxygen, further improving the phototherapy efficacy mediated by IR780 irradiation. The consumption of oxygen during the phototherapy process induces hypoxia, prompting the reduction of nitroimidazole to aminoimidazole and leading to reduced GSH synthesis, enhancing tumor cell death induced by CP. Meanwhile, the accumulation of intracellular reactive oxygen species (ROS) during phototherapy attenuates the nuclear NER pathway, further augmenting the therapy effect of CP. This strategy, by combining FPLC@IR OSNA with laser and CP, significantly promotes the therapeutic effect in vitro and notably inhibits tumor growth in both Cal27 cell line‐derived xenograft models and patient‐derived xenograft models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, P.R. China.
- New Cornerstone Science Laboratory, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijin…
- Research Unit of Nanoscience and Technology, Chinese Academy of Medical Sciences, Beijing, 100021, P.R. China.
ORCID-Profile: Chunying Chen
Förderung
- National Key Research and Development Program of China
- New Cornerstone Science Foundation
- National Natural Science Foundation of China
- Strategic Priority Research Program of the Chinese Academy of Sciences
- CAS Key Research Program for Frontier Sciences
- CAMS Innovation Fund for Medical Sciences
- Beijing Municipal Administration of Hospitals' Ascent Plan
- Beijing Nova Program
Zitieren
APA
Li, Z., Liu, Q., Wang, G., Bai, R., Li, S., Liu, T., Wang, Q., Peng, Y., Teng, F., Zhou, H., Xian, J., & Chen, C. (2025). An Oxidative Stress Nanoamplifier to Enhance the Efficacy of Cisplatin in Head and Neck Cancer. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202421481
Vancouver
Li Z, Liu Q, Wang G, Bai R, Li S, Liu T, et al. An Oxidative Stress Nanoamplifier to Enhance the Efficacy of Cisplatin in Head and Neck Cancer. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202421481
BibTeX
@article{Li2025,
author = {Li, Zhenzhen and Liu, Qiaolin and Wang, Guorong and Bai, Ru and Li, Shengmin and Liu, Tao and Wang, Qingzhen and Peng, Yufeng and Teng, Fei and Zhou, Huige and Xian, Junfang and Chen, Chunying},
title = {An Oxidative Stress Nanoamplifier to Enhance the Efficacy of Cisplatin in Head and Neck Cancer},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202421481}
}
EUVIMED